Back to search

Article

Covid-19 in the Phase 3 Trial of mRNA-1273 During the Delta-variant Surge

2021-09-22

Abstract excerpt

<h4>Background</h4> Following emergency use authorization in December 2020, the Coronavirus Efficacy (COVE) trial was amended to an open-label phase, where participants were unblinded and those randomized to placebo were offered vaccination. Emergence of the delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been associated with increased incidences of coronavirus disease 2019 (Covid...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d5fd9cab-4352-5a3c-96a6-63355ac1bbc6
DOI
10.1101/2021.09.17.21263624
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Covid-19 in the Phase 3 Trial of mRNA-1273 During the Delta-variant SurgeDOI 10.1101/2021.09.17.21263624
Select a neighboring publication to make it the new centre.